APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 213 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,695,965 | +380628.0% | 128,386 | +115.9% | 0.03% | +146.2% |
| Q4 2022 | $3,072 | -99.9% | 59,465 | +5.9% | 0.01% | -18.8% |
| Q3 2022 | $3,831,000 | -33.0% | 56,170 | -46.0% | 0.02% | -5.9% |
| Q1 2022 | $5,720,000 | +793.8% | 104,067 | +671.4% | 0.02% | +750.0% |
| Q4 2021 | $640,000 | -93.3% | 13,491 | -95.3% | 0.00% | -91.7% |
| Q3 2021 | $9,562,000 | +225.0% | 284,500 | +511.8% | 0.02% | +200.0% |
| Q2 2021 | $2,942,000 | +390.3% | 46,500 | +232.1% | 0.01% | +700.0% |
| Q1 2021 | $600,000 | -50.6% | 14,000 | -34.3% | 0.00% | -50.0% |
| Q4 2020 | $1,215,000 | +338.6% | 21,300 | +150.6% | 0.00% | +100.0% |
| Q2 2020 | $277,000 | -93.3% | 8,500 | -94.5% | 0.00% | -94.1% |
| Q1 2020 | $4,130,000 | +1063.4% | 154,000 | +862.5% | 0.02% | +1600.0% |
| Q3 2019 | $355,000 | – | 16,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |